Skip to main content
. 2012 Nov 20;2(6):620–657.

Table 2.

Genes showing aberrant expression in primary and/or advanced PCa compared to normal prostate. The selected genes are not all-inclusive, rather, they represent genes that were found in multiple DNA microarray or meta-analysis studies

Pathway or cellular function Gene name Gene symbol Expression REF
Cell cycle, cell proliferation cellular-Myelocytomatosis viral oncogene C-Myc Up [188,190,193,261]
Cyclin dependent kinase 1, 10 CDK1, 10 Up
DNA topoisomerase 2A TOP2A Up
Myb-related protein B MYBL2 Up
Androgen receptor AR Up
Estrogen receptor 1 ESR1 Up
Extracellular matrix, cell migration, cell adhesion Tumor-associated calcium signal transducer 1 TACSTD1 Down [188,191,192,197]
Cadherin-1 CDH-1 Down
Hyaluronan-mediated motility receptor HMMR Down
Metalloproteinase inhibitor 3 TIMP3 Up
Matric metalloprotease 9 MMP9 Up
Fatty acid, androgen, other metabolism Alpha-methylacyl-CoA racemase AMACR Up [195,200,201]
Fatty acid synthase FASN Up
Ornithine decarboxylase ODC Up
Signal transduction, transcription Transcription factor E2F1 E2F1 Up [190,194,196,198]
Type I inositol-3,4-bisphosphate 4-phosphatase INPP4A Up
Mitogen activated protein kinase MAPK Up
Histone-lysine N-methyltransferase EZH2 Up
c-Fos FOS Up
Forkhead box protein M1 FOXM1 Up
Ubiquitin carboxyl-terminal hydrolase 13 USP-13 Up
Transcription factor jun-B JUNB Up
Nuclear factor-κB NFκB Up
Signal transducers & activators of transcription 6 STAT6 Up
Homeobox protein NKX3.1 NKX3.1 Up
Function unknown Hepsin HPN Up [188,190,191,193,196,200]